$81.92+13.21% · 3M
Moving avg
1W+1.99%
1M+4.82%
3M+13.21%
6M+28.32%
YTD+35.09%
1Y+40.88%
3Y+50.56%
5Y-3.09%
52-week range
$48.8290% of range$85.76
Company health
Value2/6
Growth4/6
Profitability3/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1541%)
- Revenue compounding 16% a year
- Net cash on the balance sheet
Risks
- Currently unprofitable
Key statistics
Valuation
Market cap
$4.50B
Enterprise value
$4.20B
P/E ratio (TTM)
23.02x
P/S ratio (TTM)
2.96x
EV/EBITDA
23.23x
Per share & returns
EPS (TTM)
$3.43
Dividend yield
0.00%
Beta (1Y)
0.87
30-day change
+4.82%
Trading
Volume (24h)
334.17K
Previous close
$81.20
Shares outstanding
54.93M
About LivaNova PLC
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Symbol
LIVN
LivaNova PLC is a mid-cap healthcare company in the Medical - Devices industry.
Frequently asked questions
What is LivaNova PLC's market cap?
LivaNova PLC (LIVN) has a market capitalization of $4.50B.
What is LivaNova PLC's P/E ratio?
LivaNova PLC trades at a price-to-earnings (P/E) ratio of 23.02.
What exchange does LIVN trade on?
LIVN trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,148.20-0.98%
$1.08T cap
Johnson & JohnsonJNJ
$275.23-1.15%
$663.28B cap
AbbVie Inc.ABBV
$256.34-1.49%
$452.90B cap
Merck & Co., Inc.MRK
$150.34-1.31%
$371.31B cap
UnitedHealth Group IncorporatedUNH
$397.14-0.95%
$360.66B cap
Roche Holding AGSWX: ROP
CHF 357.00+0.14%
$350.91B cap
Novartis AGSWX: NOVN
CHF 129.58-1.33%
$304.13B cap
AstraZeneca PLCLON: AZN
£120.06-1.15%
$251.66B cap